Clinical trial
Preoperative Chemoradiation With Capecitabine and Cetuximab
NCT00297128 · Austrian Breast & Colorectal Cancer Study Group, Other · Completed
Key facts
| NCT number | NCT00297128 |
|---|---|
| Title | Preoperative Chemoradiation With Capecitabine and Cetuximab |
| Official title | Preoperative Chemoradiation With Capecitabine and Cetuximab Within a Multidisciplinary Therapeutic Approach in Patients With Operable T3-T4 Rectal Cancer: a Phase II Study |
| Lead sponsor | Austrian Breast & Colorectal Cancer Study Group, Other |
| Collaborators | Hoffmann-La Roche Industry Merck Gesellschaft mbH, Austria |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Rectal Cancer |
| Intervention type | Drug |
| Interventions | Capecitabine, Cetuximab |
| Enrollment | 31 |
| Start date | Oct 1, 2005 |
| Primary completion | Aug 1, 2011 |
| Completion | Nov 1, 2011 |
| First posted | Feb 28, 2006 |
| Last update posted | Dec 30, 2011 |
| Countries | Austria |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: